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Abstract 
Optic disc pit (ODP) is a rare congenital anomaly of the optic disc, which can be complicated by a maculopathy asso-
ciated with progressive visual loss. Optic disc pits are usually unilateral and sporadic in occurrence, and the develop-
ment of maculopathy is unpredictable with no known triggers. Optic disc pit maculopathy (ODP-M) is characterized 
by intraretinal and subretinal fluid at the macula, causing visual deterioration. The source of this fluid is still unclear, 
and several competing theories have suggested it may be vitreous fluid, cerebrospinal fluid, leakage from blood ves-
sels at the base of the pit or leakage from the choroid. The mechanism of pathogenesis of ODP-M has not been fully 
elucidated, but vitreous liquefaction and traction and pressure gradients within the eye have been implicated to be 
involved. There are no clear guidelines on the management of patients with ODP-M, and numerous techniques have 
been described, including laser photocoagulation, intravitreal gas injection, macular buckling and pars plana vitrec-
tomy with many different modifications. The majority of reports describe small series, and as there are no comparative 
studies there is no consensus regarding the optimal treatment for ODP-M. This review discusses the literature on the 
possible sources of fluid and mechanisms of pathogenesis in ODP-M, as well as the wide array of treatment modali-
ties and their results. Based on these, a set of recommended key concepts for the timing and choice of treatment for 
these challenging are presented.
Keywords: Optic disc pit maculopathy, Treatment, Vitrectomy, Review
© 2015 Moisseiev et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Optic disc pits are considered as part of a spectrum of 
congenital cavitary anomalies of the optic disc, which 
also includes optic disc coloboma, morning glory and 
extrapapillary cavitation [1]. Histologically, an ODP is a 
herniation of dysplastic retina into a collagen-rich exca-
vation that extends into the subarachnoid space through 
a defect in the lamina cribrosa [2]. This abnormal struc-
ture of the optic disc creates an anomalous communica-
tion between the intraocular and extraocular spaces, a 
feature shared by all congenital cavitary anomalies of the 
optic disc [1, 3].
ODPs are rare, and occur equally in men and women 
with an estimated incidence of 1 in 11,000 people [3, 4]. 
They are typically unilateral, but may be bilateral in up to 
15% of patients [4, 5]. The occurrence of ODPs is usually 
sporadic, but possible autosomal inheritance has been 
suggested in some pedigrees with multiple affected mem-
bers [6, 7]. No specific gene has been associated with 
ODP formation.
ODPs are usually seen as single, oval-shaped depres-
sions at the optic disc. They are most commonly found at 
the inferotemporal aspect of the optic disc, but may also 
be found elsewhere, including centrally [4, 8]. Occasion-
ally, an optic disc can have more than one pit [9]. ODPs 
are usually grayish, but may also be yellow or black [4, 5].
An ODP by itself is usually asymptomatic, and may 
be found incidentally. Nevertheless, the presence of 
this defect has been demonstrated to cause visual field 
defects, most commonly an enlarged blind spot and a 
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paracentral arcuate scotoma [3, 9, 10]. However, when 
an ODP is complicated by maculopathy, it may cause sig-
nificant visual deterioration. Optic disc pit maculopathy 
(ODP-M) is a term used to describe macular changes that 
occur in the context of an ODP, which include intrareti-
nal and subretinal fluid accumulation, and retinal pig-
ment changes [3, 4]. An example is provided in Fig.  1. 
Maculopathy occurs in 25–75% of patients with an ODP 
[3, 9, 11], and usually when the ODP is temporal. There is 
no known trigger for the development of ODP-M. Since 
ODP-M usually occurs in the third and fourth decades of 
life [5, 12], it has been postulated to be associated with 
posterior vitreous detachment (PVD) [1, 4, 12]. However, 
ODP-M has also been reported in pediatric patients with 
no vitreous liquefaction [1, 13].
When ODP-M is present, visual acuity (VA) is usually 
reduced to 20/70 or worse [4]. Although spontaneous 
resolution with improvement in vision has been reported 
[14, 15], the majority of cases have a poor prognosis, 
with a natural history of gradual worsening and a final 
VA of 20/200 or worse [16–18]. Therefore, interventions 
for the treatment of ODP-M are valuable, as they may 
prevent significant visual loss in these patients. With the 
advances made in ocular imaging and surgical techniques 
over the past decades, several theories of ODP-M patho-
genesis and interventions for its treatment have been 
suggested. Despite the improved insight into this unusual 
pathology, there is currently no consensus regarding its 
optimal treatment. The purpose of this literature review 
is to discuss the mechanisms of pathogenesis that may 
be responsible for ODP-M formation, and the possible 
treatment options for this challenging entity.
Review
Although ODP-M is a well-known pathology for several 
decades, the nature and origin of the fluid that is found 
intra- and sub-retinally in these patients is still controver-
sial [10, 19]. Several different mechanisms of pathogen-
esis have been proposed for ODP-M, and these theories 
have led to a variety of interventions intended to treat 
it. As ODP-M is a relatively rare diagnosis, most reports 
include case reports and small series, and there are no 
large or comparative studies whose results can serve to 
guide treatment in these cases. The following is a review 
of the theories regarding the origin of fluid in ODP-M, its 
pathogenesis and reported treatment options.
Origin of ODP‑M fluid
Over the years, four different possible sources have been 
proposed for the fluid seen in the intraretinal and subret-
inal spaces in ODP-M.
The first possible source of fluid is the vitreous. It was 
first suggested that vitreous fluid can enter the subreti-
nal space through the formation of a macular hole [19, 
20]. This initial assumption is most likely erroneous, as 
macular holes do not typically occur in patients ODP-M 
[19]. Later works on Collie dogs demonstrated that India 
ink dye injected into the vitreous was subsequently found 
in the subretinal space [21, 22]. It should be noted, how-
ever, that glycosaminoglycans, which are a component 
of the vitreous, were not found in the subretinal fluid in 
Collie dogs [21], and a direct connection between the 
vitreous and subretinal space through the ODP was not 
demonstrated by imaging or histology. A histopathologic 
study on 2 human eyes with ODP-M did report detecting 
mucopolysaccharides, which are also a component of the 
vitreous, inside the ODPs [2]. Additionally, several stud-
ies reported on the passage of gas or silicone oil from the 
vitreous cavity to the subretinal space in eyes with cavi-
tary anomalies of the optic disc, including ODP [23–25].
The second possible source of fluid is the cerebrospi-
nal fluid (CSF), which has been proposed to enter the 
intra- and sub-retinal spaces from the subarachnoid 
space through the ODP defect. Several optical coher-
ence tomography (OCT) studies have shown direct 
Fig. 1 a Fundus photograph of the left eye of a 31 year old man 
with ODP-M. A temporal ODP is noted (arrow). VA was 20/200. b A 
horizontal OCT scan through the optic disc and fovea, showing an 
abundance of intraretinal and subretinal fluid, extending towards the 
ODP. ODP optic disc pit, ODP-M optic disc pit maculopathy, VA visual 
acuity and OCT optical coherence tomography.
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communication exists between the subarachnoid space 
and the subretinal space [26–28]. Further evidence sup-
porting this concept is that gas bubbles were reported to 
percolate out of an optic nerve sheath window after pars 
plana vitrectomy and gas injection, indicating a continu-
ity between the posterior vitreous cavity and the optic 
nerve subarachnoid space [29]. Additionally, intracranial 
migration of silicone oil has been reported in a patient 
with an ODP who underwent surgery for repair of reti-
nal detachment [30]. A connection between the suba-
rachnoid and subretinal spaces has also been reported 
in morning glory anomaly [31]. It should be noted, how-
ever, that one study using intrathecal fluorescein did not 
demonstrate a connection between the subarachnoid and 
subretinal spaces [32].
The third possible source of fluid is leakage from blood 
vessels at the ODP [33]. This concept was based on the 
finding of late hyperfluorescence at the ODP in fluo-
rescein angiography, as well as in the area of macular 
elevation in eyes with ODP-M [34, 35]. However, some 
patients with ODP-M do not demonstrate this late hyper-
fluorescence [9].
The fourth possible source of fluid is from the choroid, 
through the Bruch’s membrane and peripapillary atrophy 
[36]. This source is unlikely, as subretinal fluid is often 
not observed in other diseases that cause significant cho-
rioretinal atrophy [9, 19].
ODP‑M mechanism of pathogenesis
Beyond the controversy regarding the source of fluid in 
ODP-M, the mechanism of pathogenesis for this pathol-
ogy is also unclear. ODPs are congenital, but the develop-
ment of ODP-M has no known triggers, and can occur at 
any age, from early childhood to the ninth decade of age 
[19]. Several mechanisms of pathogenesis have been pro-
posed, but none has been proven beyond all doubt.
As previously mentioned, ODP-M typically occurs in 
the third and fourth decades of life [5, 12], which is also 
the time of onset of progressive vitreous liquefaction. 
Therefore, it has been proposed that vitreous traction is 
responsible for ODP-M development. In a relatively large 
series of patients with ODP, the majority of those with 
ODP-M had PVD while the majority of those who did 
not had not yet undergone PVD [9]. Additionally, sponta-
neous resolution of ODP-M has been reported following 
completion of PVD [11]. Treatment of ODP-M with pars 
plana vitrectomy (PPV) including PVD induction is an 
effective option, suggesting that relieving vitreous trac-
tion over the ODP can achieve resolution of ODP-M [1, 
37, 38]. Several OCT studies have demonstrated vitreous 
strands over ODPs [28, 30, 40]. Several reports describe 
a membrane over the ODP [41–43], and it has been 
noted that ODP-M can develop after this membrane 
disappears, presumably due to vitreous traction over it 
[44, 45]. On the other hand, ODP-M can occur in pedi-
atric patients before the onset of any changes in the vit-
reous, and also in adults without PVD [1, 13, 19]. There 
have also been several OCT studies that did not demon-
strate any evidence of vitreous traction over OPDs [37–
40, 46]. Furthermore, ODP-M can recur following PPV, 
suggesting that vitreous traction may not be required for 
its formation [40].
Another theory is that pressure gradients within the 
eye cause migration of fluid from the vitreous into the 
subretinal space. A normal eye is a closed system, with-
out significant differences in pressure between vari-
ous compartments. In an eye with an ODP, a pressure 
gradient can exist because the intracranial pressure 
is transmitted to the ODP via the CSF. Thus, when the 
intracranial pressure is low vitreous fluid is drawn into 
the ODP, and when it rises the fluid is pushed back into 
the eye, and can dissect under or within the retina [1, 
47]. This mechanism can also explain the intraretinal, 
subretinal and intracranial migration of vitreous substi-
tutes (gases or silicone oil) in eyes with ODPs [23–25, 
29, 30].
Regardless of the source of fluid and exact patho-
physiologic mechanism of ODP-M, a sequence of retinal 
fluid accumulation and progression of its formation has 
been described by Lincoff et  al. [17], which is generally 
accepted [1, 10, 19]. First, fluid from the ODP creates a 
schisis-like inner retinal separation, associated with a 
mild cecocentral scotoma. Then, an outer layer macular 
hole develops beneath the inner layer, associated with a 
dense central scotoma. The fluid then dissects subreti-
nally creating an outer retinal detachment. This sequence 
has been supported by OCT studies [26, 27, 46]. It has 
also been previously reported that virtually all ODP-M 
cases have intraretinal fluid in the outer nuclear layer, 
and claimed that none have isolated subretinal fluid [48], 
supporting the concept that the fluid first enters the inner 
retinal layers and only later makes its way to the subreti-
nal space. It has been suggested that as fluid accumulates 
intraretinally in eyes with ODP-M, a pressure gradient is 
formed that is directing it into the retina and to the sub-
retinal space [49].
Treatments for ODP‑M
Treatment for ODP-M is warranted as the majority of 
cases suffer gradual deterioration with significant visual 
loss [16–18]. A multitude of interventions have been 
designed for the treatment of ODP-M, but none has been 
established as the treatment of choice.
Early reports described treating ODP-M with oral 
corticosteroids. This treatment was not effective, and 
resorbed fluid tended to recur following discontinuation 
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of the corticosteroids [1, 50]. Therefore, this is no longer 
considered an appropriate treatment option.
Laser photocoagulation at the temporal disc margin 
has been proposed as a treatment for ODP-M, with the 
reasoning that the laser scars will create a chorioretinal 
adhesion which will act as a barrier between the ODP and 
the subretinal space [33]. Initially, ODP-M patients were 
treated with Xenon laser and did not improve [33]. Later 
patients were treated with Argon laser, and small series 
reported absorption of fluid and reattachment of the ret-
ina in some patients [12, 51]. The time for improvement 
was variable and often long [50, 51], and the location of 
the laser treatment could also cause significant visual 
field defects.
Intravitreal gas injection has been proposed as a treat-
ment option for ODP-M, with the reasoning that pneu-
matic displacement will cause reattachment of the 
macula and improve VA [52]. This technique was used 
in small series, and resulted in visual improvement, 
although retinal reattachment was only achieved in about 
half of the cases [52, 53]. One small series of patients 
treated with a combination of intravitreal gas injection 
and laser photocoagulation temporal to the disc reported 
visual improvement and reduction in fluid in all eyes, and 
complete resolution of intraretinal and subretinal flu-
ids in 75% of eyes [54]. These studies are summarized in 
Table 1.
An alternative approach proposed for the treatment 
of ODP-M is macular buckling surgery. This procedure 
includes an implant that is fixed to the posterior aspect 
of the globe along the 6-to-12 o’clock meridian, creating 
a buckling effect under the macula [55]. This technique 
has been reported to achieve complete resolution of fluid 
in about 85% of cases, as well as significant improve-
ments in VA and visual fields [45, 55–57]. Long-term 
follow up studies of patients treated with this technique 
have demonstrated that success was maintained for over 
10 years, with very low rates of complications or recur-
rences, and long-term visual improvement [58]. Addi-
tionally, restoration of foveal outer retinal layer structure 
was documented by OCT [59]. These results are impres-
sive, but it should be noted that the surgical technique is 
complicated (intraoperative B-scan is required for exact 
positioning of the macular buckle). The technique has 
not gained popularity since its introduction 20 years ago, 
and all reports on its results are from the same group.
The predominant approach for the treatment of 
ODP-M is pars plana vitrectomy (PPV). The majority of 
the published literature on ODP-M is focused on PPV 
techniques, which have evolved along with the advances 
made in surgical technology. Several anecdotal reports 
from the late 1980’s and early 1990’s described success-
ful anatomical and visual restoration in patients with 
ODP-M who underwent PPV with or without endolaser 
to the temporal disc margin and gas tamponade [60–63]. 
In a series of 10 patients treated with PPV, laser and gas 
tamponade, visual improvement was achieved in 90% 
and complete resolution of fluid in 70% [64]. These early 
reports of successful treatment of ODP-M with PPV 
paved the way for numerous attempts to improve this 
technique.
It has been proposed that induction of complete PVD 
during surgery is essential for relief of traction required 
to achieve macular reattachment [65]. This was initially 
reported anecdotally [65, 66], and later supported by two 
different series of 11 patients [37, 67]. García-Arumí et al. 
[67] reported on 11 ODP-M patients treated with PPV, 
induction of PVD, laser and gas tamponade, achieving 
anatomical resolution and significant visual improvement 
in all cases, with only 2 recurrences. Hirakata et al. [37] 
reported on 11 ODP-M patients treated with PPV, induc-
tion of PVD and gas tamponade without laser, achiev-
ing complete resolution of fluids in 10 of them. Based on 
these results, it has been suggested that laser photocoag-
ulation at the temporal disc border may not be required 
for successful treatment of ODP-M. Gas tamponade has 
been performed in the vast majority of published cases, 
as it is used to create a temporary barrier blocking the 
passage of fluid thorough the ODP. Interestingly, anec-
dotal cases have been reported of surgical interventions 
without gas tamponade that failed to improve ODP-M, 
but when intravitreal gas was injected in a second proce-
dure the fluids have resolved [68, 69]. In another series of 
7 patients treated with PPV and PVD induction without 
Table 1 A summary of the series describing treatment of ODP-M with intravitreal gas injection
ODP-M optic disc pit maculopathy, VA visual acuity, C2F6 perfluoroethane, SF6 sulfur hexafluoride and C3F8 perfluoropropane.
References No. of cases Technique Main results Complications
Lincoff et al. [52] 3 C2F6 gas injection (no laser) Initial improvement but later recurrence None
Akiyama et al. [53] 8 SF6 gas injection (no laser) 50% resolution of intra/sub-retinal fluids
More than 1 injection often necessary
None
Lei et al. [54] 8 C3F8 gas tamponade with laser  
photocoagulation
75% resolution of intra/sub-retinal fluids
VA improved in 7 eyes
None
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laser or gas tamponade, VA had improved but the fluids 
did not resolve completely [38]. This evidence further 
strengthens the importance of gas tamponade in the 
treatment of ODP-M. Silicone oil has been very infre-
quently used in patients with ODP-M, but when used it 
had been effective [70]. It had also been reported to be 
effective in a persistent case that failed previous surgical 
treatment [71]. However, it should be noted that silicone 
has also been reported to migrate intracranially through 
an ODP [30].
One of the early reports on PPV for ODP-M described 
internal submacular fluid drainage [63]. Although suc-
cessful treatment has been reported in the absence of this 
surgical maneuver [37, 61, 62, 64–68], and even when it 
has been attempted unsuccessfully [72], it has been used 
by several surgeons. A few cases of PPV with induction 
of PVD, endolaser, submacular drainage and gas tampon-
ade have been reported to achieve complete resolution 
of fluid which was maintained over 2 years since surgery 
[73]. Additionally, a technique of subretinal drainage 
using a 42-gauge needle without the need for retinotomy 
has been described, and used successfully in one patient 
[74]. Recently, intraoperative OCT technology has been 
shown to be capable of assisting the surgeon in perform-
ing effective subretinal drainage [75].
Another controversial aspect is the necessity to peel 
the internal limiting membrane (ILM) in patients with 
ODP-M. It has been suggested to be in important com-
ponent of the surgical treatment of ODP-M [76], and a 
few cases of PPV with PVD induction, ILM peeling and 
tamponade with gas or air have been reported to achieve 
successful resolution of ODP-M [77, 78]. One case in 
which PPV with PVD induction, laser and gas tampon-
ade had failed was reported to have resolved following a 
second intervention in which the ILM was peeled [79]. 
Rizzo et  al. [80] reported on ten patients with ODP-M 
who were treated by PPV, induction of PVD, ILM peel-
ing, laser and gas tamponade, with visual improvement 
in 90% of them and complete resolution of fluids in 50%. 
Shukla et al. [81] reported on seven patients treated simi-
larly, with complete resolution achieved in six of them, 
and five achieving final VA of 20/30 or better. It has 
been suggested that patients whose ODP-M consists of a 
multi-layer schisis are more difficult to treat than those 
whose maculopathy consists predominantly of subretinal 
fluid, and that in such cases ILM peeling should be per-
formed to achieve optimal outcomes [82]. On the other 
hand, good results have been reported without ILM peel-
ing and it may not be required for successful treatment of 
ODP-M [1, 37–39, 64, 67, 83, 84].
Some authors have proposed that in addition to induc-
ing PVD, the surgeon should look for any glial tissue 
overlying the ODP and carefully peel it off during surgery. 
This maneuver has been described infrequently, and the 
ODP-M had resolved [85]. In one report on 9 eyes with 
ODP-M treated by PPV, induction of PVD, laser and gas 
tamponade, complete resolution was achieved in 6 of 6 
eyes in which glial tissue was removed from the ODP, 
compared to only 2 of 3 eyes in which this was not done 
[39]. Additionally, there are several reports that sug-
gested sealing of the ODP during surgery to prevent pas-
sage of fluid into the intraretinal and subretinal spaces. 
The first description was of a case successfully treated 
with injection of autologous platelets over the ODP [86]. 
Other techniques designed to seal the ODP include using 
an autologous scleral flap [87], inverting peeled ILM into 
the ODP [88], and using Tisseel fibrin sealant [89].
A recent series by Ooto et al. [90] reported 18 eyes with 
ODP-M treated with PPV and a creation of inner retinal 
fenestrations (which are partial thickness retinotomies) 
just temporal to the ODP. Cortical vitreous was removed 
in only five eyes, fluid-air exchange was performed in one 
eye, and ILM peeling or laser were not performed in any 
eye. This technique is based on the theory that there is 
a pressure gradient pushing fluid from the inner retina 
into the submacular space, and that through these fen-
estrations it will be diverted back into the vitreous [49, 
90]. This is the largest series of ODP-M eyes treated with 
a single technique, and its results are very good—com-
plete resolution of foveal fluid was achieved in 17 (94%) 
eyes, and VA was significantly improved with 10 (56%) 
eyes achieving 20/30 or better [90]. One previous case 
report described resolution of ODP-M following a par-
tial thickness retinotomy that connected an intraretinal 
schisis cavity to the vitreous space [91]. It should also be 
noted that a case of premature closure of such a fenestra-
tion and persistence of ODP-M has been reported [92]. 
Future studies of this technique are needed to support its 
efficacy.
A summary of the major published series of PPV treat-
ments for ODP-M is provided in Table 2.
Conclusions
Although ODPs are rare, it is likely to assume that every 
vitreoretinal surgeon will encounter several patients with 
ODP-M during his or her career. These cases are chal-
lenging to manage. Compared to other indications for 
vitreoretinal surgery, there is a paucity of literature on 
this unique pathology, the majority of which includes 
case reports and small series with no comparative stud-
ies. This makes patient counseling, expectation setting 
and decision making regarding the timing and choice of 
surgical intervention very difficult. There are no estab-
lished guidelines for the treatment of ODP-M, and no 
consensus on the mechanism of pathogenesis or the 
optimal surgical technique. Additionally, many of the 
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Table 2 A summary of the major published series of PPV treatments for ODP-M
Presented are the only studies that included more than five patients with ODP-M that were treated using a uniform PPV technique. PPV pars plana vitrectomy, ODP-M 
optic disc pit maculopathy, PVD induction of posterior vitreous detachment, laser laser photocoagulation temporal to disc, gas gas tamponade, ILMP internal limiting 
membrane peeling and VA visual acuity.
References No. of cases PPV gauge Surgical technique Main results Complications
Taiel-Sartral et al. [64] 10 20 PPV+laser+gas VA improved in 90%
Mean VA improvement of 
6.7 lines
Complete resolution in 70%
1 recurrence (10%)
None
García-Arumí et al. [67] 11 20 PPV+PVD+laser +gas 82% gained ≥2 lines of VA
Mean final VA 20/32




Hirakata et al. [37] 11 20 PPV+PVD+gas VA improved in 64%
Complete resolution 91%
Showed that laser may not 
be required for surgical 
success
1 patient developed a dense 
inferotemporal scotoma
1 patient developed an area of 
retinal atrophy
1 patient had an intraoperative 
retinal break, treated with 
laser
Ghosh et al. [71] 7 20 PPV+PVD+laser +gas 4 (57%) gained ≥2 lines of VA
4 (57%) required second 
procedure
Silicone oil was successful in 
a refractive case
1 patient developed post-
operative glaucoma and 
cataract
Rizzo et al. [80] 10 23/25 PPV+PVD+ILMP +laser+gas 70% gained ≥2 lines of VA
Complete resolution in 50%
First report with small gauge 
PPV
1 complication—macular hole
Hirakata et al. [38] 8 20/25 PPV+PVD (no gas) VA improved in 7 (88%) eyes 
Complete resolution in 88%
Suggested that gas tampon-
ade may be less important 
than induction of PVD
None
Shukla et al. [81] 7 23 PPV+PVD+ILMP +laser+gas 6 (86%) eyes gained ≥2 lines 
of VA
Final VA ≥20/30 in 5 (71%) 
eyes
4 eyes had full thickness macu-
lar holes at 1 month, but it 
closed in 3 of them
2 patients had transient 
elevated intraocular pressure
1 patient developed cataract
Avci et al. [83] 13 23 PPV+PVD+laser +gas 11 (85%) eyes gained ≥2 
lines of VA
Final VA ≥20/40 in 6 (46%) 
eyes
Complete resolution in 92%
Suggests ILMP may not 
be required for surgical 
success
2 patients developed cataracts
Gregory-Roberts et al. [39] 9 N/A PPV+PVD+glial tissue 
removal+laser +gas
Complete resolution in 8 
(89%) eyes
Higher rate of complete reso-
lution when glial tissue was 
removed over the pit
1 patient developed cataract
Ooto et al. [90] 18 25 PPV+intraretinal fenestration Complete resolution in 94%
VA improved in all eyes
11 (61%) eyes gained ≥3 
lines of VA
Final VA ≥20/30 in 10 (56%) 
eyes
None
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proposed surgical techniques are challenging to perform. 
Based on the literature review, we suggest the following 
key concepts for the timing and choice of treatment of 
patients with ODP-M.
1. Patients with ODPs that are diagnosed inciden-
tally should be counseled on the risk for devel-
opment of ODP-M. Although rates vary from 25 
to 75% [3, 9, 11] and there are no known triggers 
for it, patients should be encouraged to return for 
examination in any case of visual deterioration 
in an affected eye. Routine yearly follow-up may 
also be advised. There are no prophylactic treat-
ments, and prophylactic peripapillary laser is not 
recommended as it has not been ever studied as 
a preventative measure, and may be associated 
with creation of significant visual field defects in 
asymptomatic eyes [1].
2. Although spontaneous resolution is possible in as 
many as 25% of cases and visual improvement is pos-
sible [14, 15, 93], observation will generally lead to 
significant visual loss [16–18]. Initially it has been 
recommended to wait for spontaneous resolution for 
up to 3  months before considering surgery [4, 33], 
but today currently observation is deemed unjustified 
[10, 80]. This is especially true in the presence of pro-
gression of fluid accumulation or visual loss.
3. The most commonly used procedure for the treat-
ment of ODP-M is PPV, especially in recent years. 
Treatment with laser alone was not very success-
ful [8, 50, 51], and should currently be reserved for 
patients who cannot undergo any surgery due to 
their systemic condition. Although successful man-
agement has been reported with intravitreal gas 
injections and macular buckling, limited experience 
exists for these procedures [45, 52–59]. Macular 
buckling for ODP-M is a very technically challenging 
procedure, but experienced surgeons can consider it 
in such cases.
4. When PPV is performed, it is worthwhile to induce 
complete PVD to relieve any traction on the ODP 
[65–67]. Triamcinolone acetate may be used to 
ascertain that all vitreous has been removed from 
the posterior pole. Gas tamponade is also impor-
tant, and acts as a barrier that blocks passage of fluid 
through the OPD, and has been used in the major-
ity of cases in published literature. Perfluoropropane 
(C3F8) and sulfur hexafluoride (SF6) gases are likely 
to be equally effective in these cases [84]. We note 
that both induction of PVD and gas tamponade 
are surgical techniques that vitreoretinal surgeons 
are very experienced in as they are commonly per-
formed in surgery for other indications. These two 
elements are probably the most important in achiev-
ing success with PPV for ODP-M. Although the 
source of fluid and exact pathogenesis of ODP-M are 
unknown, these steps provide a “theoretical broad 
coverage” as they will relieve vitreous traction and 
create a barrier for pressure gradients and the pas-
sage of fluid.
5. Additional elements of surgery, such as peripapil-
lary laser, ILM peeling, subretinal drainage, peeling 
of glial tissue and sealing of the ODP are controver-
sial. Both success and failure of surgical manage-
ment have been reported with and without them, 
and available data is not enough to conclude that any 
of them are associated with better outcomes. There-
fore, these should be performed at the discretion of 
the surgeon, following a discussion of their potential 
advantages and risks with the patient.
6. Limited vitrectomy with intraretinal fenestration is 
a recently described technique that has promising 
results [90]. Future studies are required to support 
its efficacy and compare it to PPV with induction of 
PVD, gas tamponade and any of the additional ele-
ments discussed. It is possible that use of intraop-
erative OCT can facilitate the creation of the fenes-
trations. We expect such studies to be published in 
coming years.
7. The most important issue to discuss with ODP-M 
patients in whom surgery has been recommended 
is that the visual recovery is a slow and long process. 
All surgical techniques have been reported to achieve 
complete resolution of fluid and significant visual 
improvement, but these were documented after at 
least 3 months and generally only after 6–12 months 
from surgery [37, 38, 41, 45, 55–57, 64, 67, 70–73, 
80–84, 90]. This is very important for appropriate 
setting of patient expectations prior to surgery.
8. The majority of reports describe successful outcomes 
that have been maintained long term, with relatively 
low rates of ODP-M recurrence and very few postop-
erative complications.
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